Salud financiera de hoja de balance de Shanghai Haohai Biological Technology
Salud financiera controles de criterios 5/6
Shanghai Haohai Biological Technology tiene un patrimonio de accionistas total de CN¥6.0B y una deuda total de CN¥423.7M, lo que sitúa su ratio deuda-patrimonio en 7%. Sus activos y pasivos totales son CN¥7.2B y CN¥1.2B respectivamente. El BAIT de Shanghai Haohai Biological Technology es de CN¥404.8M, por lo que su ratio de cobertura de intereses es de -6.4. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥2.7B.
Información clave
7.0%
Ratio deuda-patrimonio
CN¥423.70m
Deuda
| Ratio de cobertura de intereses | -6.4x |
| Efectivo | CN¥2.69b |
| Patrimonio | CN¥6.03b |
| Total pasivo | CN¥1.21b |
| Activos totales | CN¥7.25b |
Actualizaciones recientes sobre salud financiera
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Recent updates
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt With Ease
Jul 25Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All
May 22Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Apr 17Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?
Feb 12Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Nov 14Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 28We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt
Mar 09These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Nov 25Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet
Jul 30Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price
May 08Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?
Apr 19Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Mar 04Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 03Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?
Jan 10Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly
Oct 08Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly
Jul 07Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%
May 27These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well
Apr 04Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%
Mar 16Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥3.7B) de 6826 superan a sus pasivos a corto plazo (CN¥861.5M).
Pasivo a largo plazo: Los activos a corto plazo de 6826 (CN¥3.7B) superan a sus pasivos a largo plazo (CN¥350.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 6826 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 6826 ha crecido de 0.7% a 7% en los últimos 5 años.
Cobertura de la deuda: La deuda de 6826 está bien cubierta por el flujo de caja operativo (159%).
Cobertura de intereses: 6826 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.